Upadacitinib in adults with moderate-to-severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
The Journal of Allergy and Clinical Immunology | Dec 05, 2019
The Journal of Allergy and Clinical Immunology | Dec 05, 2019